HumaGene, Inc.

HumaGene has developed IP processes for producing human fibrinogen and thrombin. With $1.2 MM in new funding, HumaGene will become profitable in 18 months.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Phoenix, AZ, US
  • Currency USD
  • Founded August 2006
  • Employees 2
  • Website humagene.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free